PO.ADV01 · 患者倡导

拉丁美洲肺癌临床试验的模式及其对患者治疗可及性和研究公平性的影响

Patterns of lung cancer clinical trials in Latin America and their implications for patient treatment access and research equity

海报缩略图:拉丁美洲肺癌临床试验的模式及其对患者治疗可及性和研究公平性的影响
编号 ADV01 展板 1 时间 4/20 02:00–05:00 区域 Section 5 主讲 Sofía Jubany
分会场 Advocates Poster Session 1
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Sofia Jubany

1

摘要 Abstract

中文摘要
拉丁美洲肺癌临床试验的模式及其对患者治疗可及性和研究公平性的影响。本项目分析了拉丁美洲肺癌临床试验参与的模式,及其对患者获得创新疗法可及性和研究公平性的影响。项目考察了限制区域参与的结构性障碍,包括早期阶段和后线研究的稀缺、研究基础设施、经费以及分子检测能力方面的差异。该工作还强调了将拉丁美洲多元化人群纳入肿瘤学研究的重要性,以提高证据的全球代表性。最后,项目探讨了患者和研究倡导者在扩大临床试验可及性、加强各利益相关方之间的协作以及促进整个区域更加公平的临床研究参与方面可以做出贡献的机会。
查看英文原文 English abstract
Patterns of lung cancer clinical trials in Latin America andtheir implications for patient treatment access and research equityThis project analyzes patterns of lung cancer clinical trialparticipation in Latin America and their impact on patient access to innovativetherapies and research equity. It examines structural barriers limitingregional participation, including the scarcity of early-phase and later-linestudies, disparities in research infrastructure, funding, and molecular testingcapacity. The work also highlights the importance of including Latin America'sdiverse population in oncology research to improve the global representativenessof evidence. Finally, it explores opportunities for patient and researchadvocates to contribute to expanding clinical trial accessibility,strengthening collaboration among stakeholders, and promoting more equitableclinical research participation across the region.

← 返回 AACR 2026 检索